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Abstract 
Aim: The study aimed to establish the oncological outcome of patients who opted for close 
surveillance with or without adjuvant chemoradiotherapy (CRT) rather than radical surgery after 
local excision (LE) of early rectal cancer (ERC) 
Method: The Royal Marsden Hospital Rectal Cancer database was used to identify rectal cancer 
patients treated by primary LE from 2006-2015. All patients were entered in an intensive 
surveillance programme. 
Results: Twenty eight of 34 analysed patients had a high or very high risk of residual disease 
predicted by adverse histopathological features for which the recommendation had been radical 
surgery. Eighteen (52%) of the 34 had received radiotherapy following LE.  Three-year 
disease free survival for the 34 patients was 85% (95% CI 78.8-91.2%) and overall survival was 
100%. Twenty two of 24 patients with a low tumour which would have required total rectal 
excision  have so far avoided radical surgery and remain disease free at a median follow up 3.2 
years.  
Conclusion: The findings suggest that with modern MRI and clinical surveillance radical surgery 
can be avoided in patients following initial LE of a histopathologically defined high risk ERC.  
These findings are comparable with those obtained after major radical resection and warrant 
further prospective investigation as a treatment arm in larger prospective trials.  
 
Key words: early rectal cancer, adjuvant chemotherapy after local excision  
 
What does this paper add to the literature?   
Under current guidelines patients with a locally excised “high risk” early rectal cancer are 
advised to have a completion major resection to avoid disease recurrence.  For patients who 
decline, the results of the current study suggest that MRI and colonoscopic surveillance with 
selective chemoradiotherapy may allow avoidance of major rectal surgery with low rates of 
disease relapse at three years. 
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Introduction 
The UK national bowel cancer screening programme is increasing the proportion of colorectal 
cancers diagnosed at an early stage. Logan et al published the results of the first one million 
screened patients and reported 42% of screen detected colorectal cancers to be stage I (1).  Early 
rectal cancer (ERC) can be defined as a Stage I, Dukes A or TNM T1 or T2 N0 cancer.  Local 
excision (LE) not compromising the oncological outcome could potentially be offered to the 
majority of such patients. The technical options for LE vary depending on the facilities and 
expertise available in the unit and include endoscopic mucosal  or submucosal resection and 
transanal surgical techniques including transanal endocopscopic microsurgery (TEM) and 
transanal resection (TAR). About half  of sessile malignant polyps resected have adverse features 
on histopathological assessment such as poor differentiation, mucinous-type histology, 
lymphovascular invasion or direct invasion deep into the submucosal layer (2).  Such features 
are associated with a 20% rate of lymph node metastasis. In this circumstance the current 
standard of practice is to offer a radical resection to avoid leaving residual locoregional disease 
(3). An anterior resection with total mesorectal excision (TME) after local excision may be 
difficult owing to inflammation and fibrosis especially if it is delayed,. Furthermore, patients 
may not accept such major surgery with its mortality and morbidity particularly if there is a high  
probability that there will  be no residual tumour in the resection specimen.  
 
Investigating ERC to define the role of both local excision and adjuvant therapy was the most 
important research priority agreed by the recent Delphi survey of over 900 colorectal surgeons of 
the Association of Coloproctology of Great Britain and Ireland (ACPGBI) (4). Previously 
published data do not support the use of adjuvant chemoradiotherapy (CRT) after local excision 
of high risk T1 or T2 cancers as an alternative to completion major resection.  Paty et al report 
that adjuvant CRT  after local excision only delays the time to local recurrence from 1.1 years to 
2.1 years which was 7% for T1 and 24% for T2 in their unit  (5). The prospective phase II study 
by Greenberg et al reported ten year rates of disease-free survival of 75% and 64% for patients 
with locally excised T1 and T2 lesions (6). This study did not, however, use magnetic resonance 
imaging (MRI) or ultrasound to stage the tumour before treatment but instead relied on 
computerized tomography (CT), carcinooembrionic antigen (CEA) estimation and clinical 
assessment (6) and the protocol of follow up after local excision was not stipulated. 
In recent years there have been improvements in the assessment of early rectal cancer and 
surveillance by high-resolution MRI and also in the technique of local excision. In our practice 
patients  with early rectal cancer treated by LE undergo high-resolution MRI to identify any 
extramural macroscopic disease, such as malignant lymph nodes or extramural vascular 
Page 4 of 15 
invasion,.  In accordance with national guidelines the policy in our hospital was to offer 
completion radical surgery if adverse histology features were reported after local excision (3). If 
radical surgery was declined we gave patients the alternative option of adjuvant chemo-
radiotherapy and intensive follow up. Here we report on our experience, our surveillance 
protocol and the oncological outcomes of such patients with adverse histology who opted for 
follow up with or without adjuvant therapy rather than completion radical surgery. 
 
Method 
Patients  
The study was registered as a service evaluation protocol and approved by the hospital research 
data management and statistical unit.  The Royal Marsden Hospital Rectal Cancer database was 
used to identify rectal cancer patients treated by local excision from 2006-2015. All patients 
referred to the Royal Marsden MDT who underwent LE or TEM for a rectal lesion proven to be 
adenocarcinoma were included.  Patients were excluded if they had had preoperative CRT before 
local excision. Thirty-six consecutive patients were found applying the above-mentioned criteria, 
but two patients who had a piecemeal resection of a dysplastic adenoma with no confirmation oc  
malignancy on histopathology were excluded from the final analysis. there were therefore 34 (22 
male) patients of mean age 63 (39-83) years with an early rectal carcinoma (ERC) who were 
eligible for analysis  (Figure 1).   
 
Local Excision  
Local excision was performed by transanal endoscopic microsurgery (TEM) or transanal 
resection (TAR).  The indications included diagnostic and therapeutic.  It was carried out 
according to the preoperative features of the tumour as follows:  
i) for tumours considered to be malignant with suspected invasion of less than the full thickness 
of the muscularis propria (MP), a full thickness local excision by transanal microrsurgery (TEM) 
or transanal resection [TAR]) was carried out.  
ii) for tumours not considered to be invasive on clinical assessment, a local excision with 
submucosal or partial or full thickness resection of the MP was performed with diagnostic intent, 
which then turned out to be the final treatment after histopathological examination of the surgical 
specimen.  
The initial decision to perform local excision was based predominantly on clinical assessment by 
digital rectal examination and rectoscopy and took into account the further factors of biopsy 
findings, size of lesion, patient preference, comorbidity and the feasibility of local excision. The 
recommendation to offer radical surgery was based on the histopathological assessment of the 
Page 5 of 15 
local excision surgical specimen taking into account known prognostic factors for recurrence 
after local excision, in accordance with the ACPGBI guidelines (3). 
 
Adjuvant therapy 
When completion surgery was declined by the patient but high risk features were 
considered present, adjuvant CRT was offered and 18/34 (53%) of patients chose to have 
post local excision external beam radiotherapy (EBRT). Treatment was delivered by a 
conformal technique and the dose fractionation depended on the histopathological features 
and the estimated local recurrence risk.  For patients with a clear margin on the local 
excision specimen, where microscopic involvement of mesorectal lymph nodes was 
perceived as the main risk, 45Gy in 25 fractions were given to the pelvis to include the 
mesorectum with concomitant Capecitabine 825mg/m2 twice daily.  Where there was an 
involved or close margin in the local excision specimen, the tumour bed was boosted with 
further of EBRT delivering 9Gy in 5 fractions to five and 5.4Gy to 3 fractions to two 
patients. 
 
Surveillance 
Patients who received adjuvant CRT were followed up by the Clinical Oncology team at three 
monthly intervals for the first two years and thereafter at six monthly intervals to five years. An 
examination was carried out at every clinic visit with the results of MRI and CEA available at 
each visit.  An annual CT scan was performed according to usual protocol for patients with 
colorectal cancer.  Patients having local excision without adjuvant chemoradiation were followed 
at similar intervals by the surgical team. 
 
Magnetic resonance imaging  
MR was performed on 1.5T MR systems (Siemens) using a body-matrix phased array surface 
coil centred over the pelvis. After localizer sequences, high-resolution T2 weighted TSE scans 
were acquired in coronal and sagittal planes, followed by high-resolution (HR) oblique-axial 
scans (perpendicular to the long axis of the rectum with 160 mm FOV, 3 mm slice thickness, no 
inter slice gap and matrix 256x256).  
We used the routine reporting proforma  of the radiological department at The Royal Marsden 
Hospital. The site of local excision was determined, by interpreting low signal intensity as the 
scar, regardless of whether it was confined to the rectal wall or extended into the mesorectum. 
Irregular intermediate signal intensity at the site was interpreted as showing the presence of 
residual or recurrent tumour. The craniocaudal length and thickness of the excised area was 
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measured, assuming that any progressive increase in size or thickness of the scar or treated 
tumour site or new intermediate signal intensity within the mesorectum was suggestive of 
recurrence.  If recurrence or persistence of tumour was suspected in the lumen or the 
mesorectum on either MRI or clinical assessment, the patient was discussed in the MDT. 
 
Statistical analysis  
Data were expressed as median and range or as a proportion of the denominator of 34 with the 
95% confidence interval (CI). Overall survival (OS) was calculated measured from the date of 
local excision to the most recent follow up date or death from any cause. The disease free 
survival (DFS) was calculated from the date of surgery to the point of the appearance of 
metastatic or local disease,or cancer related death. Survival curves for OS and DFS were 
obtained  using the Kaplan–Meier method. Patients without an event were censored at the last 
follow up. A p-value of < 0.05 was taken as being statistically significant. Statistical analysis 
was performed using SPSS version 19.0. 
 
Results 
 Patients 
Local excision  wa undertaken in 34 patients. In 19 the procedure was diagnostic and in the 
remaining 15 patients it  was therapeutic. Twelve (58%) of the 19 and 13 (82%) of the 15 
patients had had a preoperative MRI. Six in the diagnostic and three in the therapeutic group had 
TEM.  Eighteen patients were referred from the local network of hospitals where MRI for ERC 
was agreed policy and of these 17 (94%) had had a preoperative MRI (Table 1).  
 
Histopathology 
The final histology of the 34 surgical specimens was as follows: pT1 Sm1-2; 16 (47%) , pT1 
Sm3; 10 (29%), pT2; 7 (21%), pT3b; 1(3%) (Table 2). The resection margin was less than 1 mm 
in 18 (53%) of the 34 specimens and 1-2 mm in five (15%) with missing data in 7 (21%). 
Intramural lymphovascular invasion (LVI) was identified in 13 (38%). This increased with the 
depth of invasion being present in 28.5% of T1 Sm2 tumours ,40% of T1sm3 tumours and 57% 
of T2 tumours.  Information on tumour budding status was missing in nine patients.   
Poorly differentiated tumours were found in 9% of cases and a further 23% showed mucin 
histology. Therefore of the 34 patients undergoing local excision, 28 (82%) were categorized 
into group of high or very high risk for local recurrence according to ACPGBI recommendations 
(3).  
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Treatment 
In 25 (73%) patients the lower border of the tumour was less than 6cm from the anal verge. In 24 
(71%) the MDT recommended abdominoperineal excision of the rectum (APER). This was 
based on assessment of the potential surgical plane of dissection required to achieve clearance of 
more than 1mm.  Overall the MDT advised radical surgery or adjuvant chemoradiotherapy in 28 
(82%) patients, but 18 opted to be treated by adjuvant CRT and surveillance and 10 declined 
CRT and chose clinical and MRI surveillance. In the patients opting for adjuvant CRT and close 
surveillance, the median interval from the local excision to  starting CRT was 62.5 (30-136) 
days.  
Patients were analysed in three groups according to the management strategy after local excision 
These included i) 18 patients at high-risk of local recurrence who received adjuvant CRT (Group 
1), ii) 10 patients who opted for surveillance with no adjuvant CRT (Group 2) and iii)  6 patients 
at low risk for local recurrence (Group 3). The median follow up for all patients was 49 (19-121) 
months. The overall survival (OS) at 4.0 years was 100%. At a median follow-up interval of 49 
(14-121) months (Table 3) none of the patients in the management Groups 1 and 3 developed 
local or distant recurrence.  
 
Meanwhile two patients who declined further treatment group (the second group in the survival 
curve analysis) were identified as having residual extramural disease and macroscopic residual 
tumour at the site of local excision on the first surveillance MRI and colonoscopy and underwent 
radical surgery. In both cases radical surgery, consisted of APE, was performed within three 
months after primary LE. The final histopathological examination of the surgical specimen 
confirmed pT3bN0R0 and T2N0R0 adenocarcinoma. None of these patients developed distant 
metastases. A further two patients of the second group developed local recurrence at 6 and 7 
months after LE surgery, and one (10%) developed distant lung metastases at 11 months (Figure 
1).   
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Fig. 1. Disease free survival after local excision 
 
One patient experienced a local recurrence at seven months after local excision. 
Histopathological examination had shown a pT1sm2 tumour containing mucin. The patient had 
had no adjuvant CRT and  an extramural mucinous recurrence was diagnosed on a routine 
follow-up MRI scan (Figure 2). The patient underwent APE for ypT2N0 tumour, and remains 
under surveillance without pelvic recurrence or distant metastasis.  
The other case of local recurrence occurred in a patient treated by a LE for yT1sm3R1 
moderately differentiated adenocarcinoma. Following the actual excision a defect in the rectal 
wall, which appeared to be abutting the mesorectal fascia was seen. The patient declined any 
further treatment and underwent close surveillance. A six months MRI scan showed a new area 
of nodularity with intermediate signal intensity at the site of the surgical scar. The patient 
subsequently received CRT which was commenced 247 days after LE. An MRI scan 
immediately following this treatment showed a good response, but a subsequent MRI within 3 
months of the end of  adjuvant CRT showed tumour regrowth which was confirmed by rectal 
biopsy to be  carcinoma. The patient eventually underwent an APE and has  no evidence of 
recurrent or metastatic disease at 82 months from the initial LE.  
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Fig. 2. A post-TEM MRI shows a well-defined scar (yellow arrow) at the site of excision of a low rectal pT1sm2 
tumour containing mucin. At seven months after surgery an MRI scan demonstrated an area of extramural 
hyperintense signal at the site of the TEM scar, highly suspicious of local recurrence. Three months later disease 
progression was noted and extramural mucinous mass had now infiltrated the rectal wall at the site of the scar. A 
biopsy confirmed recurrence. MRI successfully had identified relapse before clinical evidence of recurrence by 7 
months). 
 
One patient from the 2
nd
 group developed a pulmonary metastasis within 11 months after local 
excision of a poorly differentiated pT1sm3 adenocarcinoma. The metastasis was resected with 
no further sites of relapse in the 36 months following local excision.   
 
 
Discussion 
The present study demonstrated that patients undergoing local excision of an early rectal cancer 
with histopathological features indicating a high risk of recurrence who opted for adjuvant CRT 
and close surveillance rather than major surgery, had no recurrence either local or distant and a 
three year disease free survival of 100%. In contrast  patients with a high-risk locally excised 
tumour, who chose close surveillance but no further treatment, experienced a local recurrence 
rate of 40%.  Overall 22 (92%) of the 24 patients included in the study  successfully avoided a 
recommended APE for at least 3 years.  
We acknowledge that the study is not a prospective trial but rather an analysis of a prospective 
patient database.  We do not have data of the outcome of patients with tumours of a similar stage 
who opt for completion major surgery as in our practice, most patients opt for surveillance. We 
also do not have experience of significant numbers of patients undergoing surveillance without 
adjuvant therapy. Nevertheless, the safety of completion major resection after local excision of 
early rectal cancer with a high histopathological risk of recurrence has been reported by others to 
be very low. Thus Hahnloser et al reported a local recurrence rate of 3% after completion major 
resection following the local excision of high risk ERC which was no different from the  5% rate 
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of local recurrence after primary radical surgery (7).  Radical surgery in early rectal cancer after 
a previous local excision performed by whatever technique can be technically difficult  owing to 
the presence of fibrosis and inflammation. Adjuvant chemoradiotherapy in  patients at high risk 
of local recurrence after LE is not included in the published treatment guidelines and appears to 
have been considered an alternative option rather than standard treatment as there are insufficient 
data to support this approach. The most recently published systematic review on ERC included 
ten studies that evaluated local excision combined with adjuvant CRT. This showed that at a 
range of 30.5-115.2 months median overall survival (OS) was 75 (66-80.6) % and DFS was 74 
(64-85.2) % (8), although some of the older studies included in the review had not used modern 
MRI for the initial assessment and the subsequent follow up.  
The present study has shown that when a patient having local excision of a high risk ERC 
declines recommended major surgery, close surveillance is effective. Thus the single patient who 
developed metastatic disease was identified in our surveillance programme and underwent early 
metastectomy and the four patients with local recurrence underwent abdominoperineal excision 
with curative intent. In all of these patient local recurrence  was identified  on high resolution 
MRI and confirmed by biopsy. MRI is superior to endoscopy for assessing the local excision 
scar during follow up as it can visualise the extraluminal component and  the whole mesorectum 
and pelvic side wall can be monitored, . This may account for the improved safety and survival 
seen in the present series. 
Recurrence has been reported up to seven years after local excision and adjuvant therapy, but the 
vast majority of relapses occur in the first three years (5, 6). Contemporary trials evaluating local 
excision also reported the oncological endpoints at a three years.  The findings of this study 
therefore raise the possibility of discussing surveillance rather than radical surgery as an initial 
option in patients with a locally excised ERC even one with high risk histopathological features.   
Larger prospective studies with longer follow up are needed, but if the results of the present 
study are confirmed they would be a significant advance in the treatment of ERC. Institutions 
intending to study the question of management after LE for ERC should be confident of the  
quality of their tumour staging and surveillance programmes. For a rectal adenoma removed 
endoscopically and found to contain unexpected malignancy, the results of the present study 
agree with the literature that further therapy, whether CRT or surgery, can be avoided in a 
proportion of patients.  It also suggests, however, that an ERC treated by local excision which 
contains adverse histopathological features should be considered for adjuvant CRT rather than 
having major surgery.  Whatever option is chosen, close surveillance should be performed 
including high resolution pelvic MRI to exclude any residual or recurrent intra and extramural 
disease.  
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It is important to recognise that a comparable oncological outcome after subsequent major 
surgery or surveillance with or without CRT, must include the consideration of other factors 
including mortality, morbidity, function and quality of life. Selective adjuvant 
chemoradiotherapy based on carefully documented histopathology together with a policy of 
careful MRI-based surveillance, in patients having local excision for an early rectal cancer 
appears to be feasible and warrants evaluation by future research.      
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Table 1. The number of patients who underwent diagnostic and therapeutic local excision 
 
 
Preoperative  
MRI 
 (Y/N) 
Mucosal 
resection 
Full thickness 
resection of 
the rectal wall 
pT stage 
Preoperative 
biopsy  
LE/TAR TAE TEM pT1sm1 pT1sm2 pT1sm3 pT2 pT3b 
Benign 12/7 7 6 6 1 8 6 3 1 
Malignant 13/2 5 7 3 1 6 4 4 0 
Total 25/9 12 13 9 2 14 10 7 1 
MRI= magnetic resonance imaging, LE= local excision, TAR= transanal rexection,, TEM= transanal endoscopic 
microsurgery,  
 
Table 2. The results of histopathological examination of the excised  local excision specimen 
 
pT 
T1sms1 T1sm2 T1sm3 T2 T3b 
pR 
<1 mm  5 3 4 1 
1-2 mm 1 1 1 2  
>2 mm  4 5   
missing 1 4 1 1  
pLV 
present  4 4 4 1 
absent 1 7 6 2  
missing 1 3  1  
Tumour budding 
present  2 3 4 1 
absent  8 5 2  
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missing 2 4 2 1  
pG 
well/moderately 1 7 5 4  
poorly   2  1 
mucinous 1 3 2 2  
missing  4 1 1  
Risk for local 
recurrence 
Low risk (<5%) 1 0 0 0 0 
Medium risk (5-10%) 1 4 0 0 0 
High risk (8-15%) 0 1 0 0 0 
Very-high risk (>20%) 0 9 10 7 1 
Distance from the 
anal verge 
> 6 cm 1 4 2 2  
<6 cm 1 10 8 5 1 
Adjuvant CRT 0 5 6 7 1 
Local recurrence 0 1 1 0 0 
Distant metastases  0 0 1 0 0 
Total 2 14 10 7 1 
pR – resection margin  
pLV- lymphovascular invasion 
pG- tumour differentiation grading  
 
 
Table 3. Duration of follow up  
Months 0 6 12 18 24 30 36 42 48 
Total number of patients  34 34 34 33 31 30 27 21 19 
Number receiving CRT  18 18 18 18 18 17 14 12 11 
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Figure 1: Flow chart of the study 
RMH = Royal Marsden Hospital, MRI = magnetic resonance imaging, LE= local excision 
CRT = chemoradiotherapy 
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High-resolution MRI protocol for the follow-up after local excision 
Scar at site of primary excision 
Identification of scar 
Height(mm)  of scar from anal verge 
Longitudinal length (mm)  
Thickness (mm) 
Is there evidence of intermediate signal intensity in the scar or within or outside the rectal wall 
 
Nodal Spread:  
Mesorectum imaged at high resolution up to the level of S1   
Benign appearing nodes (yes/no) ? 
Are morphologically suspicious lymph nodes identified within the mesorectum? 
Has there been a change from previous MRI ? 
Malignant pelvic sidewall nodes 
Other pelvic viscera:  
Do the pelvic viscera appear morphologically normal? 
Pelvic peritoneum 
Is there MR evidence of pelvic peritoneal disease? 
Bony pelvis:  
Suspicious bony lesions? (yes/no) 
Opinion 
MR evidence or no evidence of locoregional  recurrence 
 
